Abstract
To evaluate the long-term effects of drospirenone (DRSP)/ethinylestradiol (EE) alone, metformin alone, and DRSP/EE-metformin on CD4(+)CD28(null) T lymphocytes frequency, a cardiovascular risk marker, in patients with hyperinsulinemic polycystic ovary syndrome (PCOS).
| Original language | English |
|---|---|
| Pages (from-to) | 1508-1517 |
| Number of pages | 10 |
| Journal | Reproductive Sciences |
| Volume | 20 |
| Issue number | 12 |
| DOIs | |
| Publication status | Published - 2013 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Obstetrics and Gynaecology
Keywords
- Adolescent
- Adult
- Analysis of Variance
- Androstenes
- Antigens
- CD28
- CD4 Lymphocyte Count
- CD4+CD28null T-lymphocytes
- CD4-Positive T-Lymphocytes
- Cardiovascular Diseases
- Chi-Square Distribution
- Ethinyl Estradiol
- Female
- Humans
- Hyperinsulinism
- Hypoglycemic Agents
- Metformin
- Polycystic Ovary Syndrome
- Reproductive Control Agents
- Risk Factors
- Rome
- Time Factors
- Treatment Outcome
- Young Adult
- drospirenone
- ethinylestradiol
- metformin
- polycystic ovary syndrome
Fingerprint
Dive into the research topics of 'Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver